Biophysical Journal 73: 157-167 (1997)
© 1997 the Biophysical Society

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Degtiar, V E Articles by Hering, S Search for Related Content PubMed PubMed Citation Articles by Degtiar, V E Articles by Hering, S

Calcium channel block by (-)devapamil is affected by the sequence environment and composition of the phenylalkylamine receptor site.

Institut für Biochemische Pharmakologie, Innsbruck, Austria.

ABSTRACT

The pore-forming alpha 1 subunit of L-type calcium (Ca2+) channels is the molecular target of Ca2+ channel blockers such as phenylalkylamines (PAAs). Association and dissociation rates of (-)devapamil were compared for a highly PAA-sensitive L-type Ca2+ channel chimera (Lh) and various class A Ca2+ channel mutants. These mutants carry the high-affinity determinants of the PAA receptor site in a class A sequence environment. Apparent drug association and dissociation rate constants were significantly affected by the sequence environment (class A or L-type) of the PAA receptor site. Single point mutations affecting the high-affinity determinants in segments IVS6 of the PAA receptor site, introduced into a class A environment, reduced the apparent drug association rates. Mutation I1811M in transmembrane segment IVS6 (mutant AL25/-I) had the highest impact and decreased the apparent association rate for (-)devapamil by approximately 30-fold, suggesting that this pore-lining isoleucine in transmembrane segment IVS6 plays a key role in the formation of the PAA receptor site. In contrast, apparent drug dissociation rates of Ca2+ channels in the resting state were almost unaffected by point mutations of the PAA receptor site.

This article has been cited by other articles:

				I. Bodi, S. E. Koch, H. Yamaguchi, G. P. Szigeti, A. Schwartz, and G. Varadi The Role of Region IVS5 of the Human Cardiac Calcium Channel in Establishing Inactivated Channel Conformation. USE-DEPENDENT BLOCK BY BENZOTHIAZEPINES J. Biol. Chem., May 31, 2002; 277(23): 20651 - 20659. [Abstract] [Full Text] [PDF]

				S. Berjukow, F. Gapp, S. Aczel, M. J. Sinnegger, J. Mitterdorfer, H. Glossmann, and S. Hering Sequence Differences between alpha 1C and alpha 1S Ca2+ Channel Subunits Reveal Structural Determinants of a Guarded and Modulated Benzothiazepine Receptor J. Biol. Chem., March 5, 1999; 274(10): 6154 - 6160. [Abstract] [Full Text] [PDF]

				S. Hering, S. Aczel, R. L. Kraus, S. Berjukow, J. Striessnig, and E. N. Timin Molecular mechanism of use-dependent calcium channel block by phenylalkylamines: Role of inactivation PNAS, November 25, 1997; 94(24): 13323 - 13328. [Abstract] [Full Text] [PDF]

				T. W. Loo and D. M. Clarke Defining the Drug-binding Site in the Human Multidrug Resistance P-glycoprotein Using a Methanethiosulfonate Analog of Verapamil, MTS-verapamil J. Biol. Chem., April 27, 2001; 276(18): 14972 - 14979. [Abstract] [Full Text] [PDF]

				S. Sokolov, E. Timin, and S. Hering On the Role of Ca2+- and Voltage-Dependent Inactivation in Cav1.2 Sensitivity for the Phenylalkylamine (-)Gallopamil Circ. Res., October 12, 2001; 89(8): 700 - 708. [Abstract] [Full Text] [PDF]